A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

The successive emergences and accelerating spread of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages and evolved resistance to some ongoing clinical therapeutics increase the risks associated with the coronavirus disease 2019 (COVID-19) pandemic. An urgent intervention fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yanyun, Shi, Rui, Zhang, Ying, Duan, Xiaomin, Li, Li, Zhang, Jing, Wang, Fengze, Zhang, Ruixue, Shen, Hao, Wang, Yue, Wu, Zheng, Peng, Qianwen, Pan, Ting, Sun, Wanwei, Huang, Weijin, Feng, Yue, Feng, Hui, Xiao, Junyu, Tan, Wenjie, Wang, Youchun, Wang, Chenhui, Yan, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371079/
https://www.ncbi.nlm.nih.gov/pubmed/34404805
http://dx.doi.org/10.1038/s41467-021-25331-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371079/
https://www.ncbi.nlm.nih.gov/pubmed/34404805
http://dx.doi.org/10.1038/s41467-021-25331-x

Ejemplares similares